Company / SG&A per Share
Benitec Biopharma Inc. SG&A per Share History
FY2020-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$5.02
FY2021
5-year range
$5.02 / $5.39
FY2020-FY2021
Trend
-6.7%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
5.02 in FY2021.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, sg&a per share decreased 6.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.32 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $5.02 | -6.7% |
| FY2020 | $5.39 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026